The JNK interacting protein JIP-1 and insulin like growth factor II genes are co-expressed in human embryonic tumours

Anticancer Res. 2005 Mar-Apr;25(2A):1075-8.

Abstract

JNK interacting protein 1 (JIP-1) is a pivotal scaffolding protein in the JNK signalling pathway. It is believed to play a role in the mediation of mitogenic messages from the plasma membrane to the cell interior. Recent evidence suggests that the JIP-1 gene is co-regulated with the insulin like growth factor II (IGF II) gene, thereby contributing to the growth-promoting effects of this potent growth factor. In this study, fourteen embryonic tumours were examined for the expression of JIP-1 and IGF II. It was found that, irrespective of histological type and expression level, the two genes showed a high degree of co-variation in the sense that high IGF II expression was followed by high expression of JIP-1. This finding further supports the notion that JIP-1 and IGF II act in concert to enhance cell proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / biosynthesis*
  • Adaptor Proteins, Signal Transducing / genetics
  • Blotting, Northern
  • Carcinoma, Embryonal / genetics*
  • Carcinoma, Embryonal / metabolism*
  • Carcinoma, Embryonal / pathology
  • Humans
  • Insulin-Like Growth Factor II / biosynthesis*
  • Insulin-Like Growth Factor II / genetics
  • Male
  • Poly A / metabolism
  • RNA, Neoplasm / genetics
  • RNA, Neoplasm / metabolism
  • Testicular Neoplasms / genetics*
  • Testicular Neoplasms / metabolism*
  • Testicular Neoplasms / pathology

Substances

  • Adaptor Proteins, Signal Transducing
  • MAPK8IP1 protein, human
  • RNA, Neoplasm
  • Poly A
  • Insulin-Like Growth Factor II